Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at CZK 2.1T, ahead of Eli Lilly (CZK 1.45T) and Merck & Co (CZK 1.45T). Figures as of 20 Nov 2026, 11:36 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonCZK 2.1T
- Median
- CZK 71.4B
- Combined market value
- CZK 110.65T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 2.1T | CZK 14.34T | CZK 5,956.58 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | CZK 1.45T | CZK 26.84T | CZK 30,126.73 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | CZK 1.45T | CZK 7.3T | CZK 2,961.34 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | CZK 1.4T | CZK 3.5T | CZK 614.08 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | CZK 1.36T | CZK 11.18T | CZK 6,322.26 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | CZK 1.31T | CZK 6.07T | CZK 3,911.22 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | CZK 1.22T | CZK 6.37T | CZK 3,371.84 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | CZK 1.08T | CZK 2.47T | CZK 1,027.03 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | CZK 1.07T | CZK 2.66T | CZK 1,300.84 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | CZK 1.02T | CZK 3.82T | CZK 866.71 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | CZK 988.4B | CZK 4.01T | CZK 2,316.05 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | CZK 966.8B | CZK 2.14T | CZK 1,066.27 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | CZK 629.2B | CZK 1.53T | CZK 477.39 | 0.66% up | 50% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 384.8B | CZK 1T | CZK 859.35 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | CZK 319.8B | CZK 2.13T | CZK 20,588.27 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | CZK 318.9B | CZK 508.2B | CZK 443.28 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | CZK 267.6B | CZK 2.94T | CZK 11,609.47 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | CZK 211.1B | CZK 731.9B | CZK 1,801.42 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | CZK 186.1B | CZK 124.4B | CZK 182.84 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | CZK 119.1B | CZK 1.02T | CZK 8,912.35 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | CZK 105.1B | CZK 293B | CZK 586.20 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 95.2B | CZK 338.4B | CZK 5,272.27 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | CZK 82.9B | CZK 706B | CZK 1,144.98 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | CZK 82.8B | CZK 441.5B | CZK 3,296.03 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 79.7B | CZK 275.7B | CZK 330.67 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | CZK 71.8B | CZK 265.3B | CZK 1,369.52 | 0.02% down | 12% up | ||
| 27 | United TherapeuticsUTHR · Health Care | CZK 71B | CZK 530.9B | CZK 12,466.59 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | CZK 67.3B | CZK 166.2B | CZK 476.95 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | CZK 53B | CZK 868.2B | CZK 1,509.99 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | CZK 38.6B | CZK 108.6B | CZK 1,300.51 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | CZK 32.9B | CZK 173B | CZK 1,029.70 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | CZK 22.9B | CZK 69.6B | CZK 358.99 | 0.92% down | 43% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 21.4B | CZK 205.5B | CZK 8,846.35 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | CZK 21B | CZK 101.1B | CZK 606.94 | 0.62% down | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 18.5B | CZK 137.6B | CZK 973.29 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | CZK 17.8B | CZK 374.4B | CZK 5,707.29 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | CZK 17B | CZK 158.6B | CZK 1,448.90 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 15.1B | CZK 163.9B | CZK 2,085.61 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | CZK 14.2B | CZK 159.1B | CZK 3,025.34 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | CZK 13.7B | CZK 218.7B | CZK 1,446.67 | 1.88% down | 103% up | ||
| 41 | InsmedINSM · Health Care | CZK 13.5B | CZK 706.6B | CZK 3,221.11 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | CZK 11.6B | CZK 139B | CZK 2,129.64 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | CZK 11.2B | CZK 339.6B | CZK 1,743.23 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | CZK 10.9B | CZK 103.4B | CZK 1,076.97 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | CZK 6B | CZK 128B | CZK 6,398.07 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 4.2B | CZK 180.6B | CZK 2,604.36 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | CZK 2B | CZK 159.8B | CZK 1,147.43 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | CZK 1B | CZK 180.5B | CZK 2,765.35 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | CZK 184.2M | CZK 629.4B | CZK 868.71 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | CZK 45.4M | CZK 106.5B | CZK 1,891.51 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | CZK 0 | CZK 206.7B | CZK 2,176.91 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | CZK 0 | CZK 193.8B | CZK 6,932.32 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2976 CZK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (CZK 2.1T), Eli Lilly (CZK 1.45T) and Merck & Co (CZK 1.45T) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 11:36 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of CZK 110.65T as of 20 Nov 2026, 11:36 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.